Drug Safety Concerns: Four Indian Pharma Companies Issue Recalls in Last Three Months
It’s been a rough start to 2025 for Indian pharmaceutical giants. Four of India’s biggest generic drug producers issued product recalls in the last three months.
CPA Recommendations for Implementing Tariffs Pursuant to the America First Trade Policy Memorandum
CPA cautions against adopting a reciprocal tariff strategy aimed primarily at negotiating lower foreign trade barriers and more favorable investment conditions abroad. A reciprocal tariff strategy that prioritizes foreign governments’ willingness to reduce their trade barriers or be more receptive to foreign investment is in conflict with the stated goals of the America First Trade Policy Memorandum and undermines the predictability and stability American businesses need to confidently invest in long-term domestic production.
Importers Front-Run Global Tariffs; Deficit Expands a Record Breaking 34% in January
It’s a straight line up. The goods and services deficit kicked off January by rising a record 34% over December. Importers are front running tariffs and getting in their orders before everything changes, likely at some point after April 1.
Why Overhauling Global Trade Rules Is a Long-Term Challenge, Not a Two-Month Fix
It took nine months to rescue two astronauts stuck on the International Space Station this weekend, yet somehow President Trump is expected to rewrite global trade rules between the U.S. and 166 World Trade Organization-member countries in less than two months.
CPA Highlights Critical Role of NSF and NIH in Driving U.S. Innovation and Industrial Leadership
Strong federal investment in the National Science Foundation and National Institutes of Health is vital for American innovation, economic growth, and national security.
CPA Praises Trade Ranking Member Sánchez’s Bill to Close De Minimis Loophole
For years, the de minimis loophole has flooded the U.S. with uninspected, untaxed, and often dangerous goods—from counterfeit products to fentanyl precursors fueling America’s opioid crisis.
Wall Street’s Overblown Tariff Fears Not Based in Reality
Investors’ panic is misguided—history proves President Trump’s tariffs boost investment, jobs, and long-term American prosperity.
CPA Economist: Tariffs Don’t Drive Inflation
Tariffs are an effective tool for boosting domestic production. They stimulate critical domestic investment and increase U.S. manufacturing capacity. It’s past time to abandon the outdated dogma of unregulated free trade — and start focusing on rebuilding American industry to create jobs and ensure long-term economic resilience.
House Select Committee on CCP Hears Testimony From 9 Companies Detailing Their Struggles Against Chinese Trade Violators
Nine different companies joined members of the House Select Committee on China at a press conference on Wednesday to talk about their battles with “China trade cheats” that have cost them a fortune. Most of them closed factories, or rolled back investment. Despite tariffs and anti-dumping (AD/CVD) trade case victories, the battle continues.
New CPA Economic Report Highlights Importance of President Trump’s Steel and Aluminum Tariffs
CPA’s report demonstrates that previous tariff exemptions and exclusions significantly weakened the effectiveness of the original tariffs imposed in 2018.